Global Custom Market Research Reports Provider Company

phone

Dry Eye Syndrome: Epidemiology Forecast to 2026

  • Published Date: 06 Jun 2018
  • Number of Pages: 29
  • Category: Pharmaceuticals
  • Country: Global
Dry Eye Syndrome: Epidemiology Forecast to 2026

Summary

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye characterized by dryness, decreased tear production, or increased tear film evaporation. Patients with DES experience symptoms of discomfort, such as visual disturbance and tear film instability. Middle-aged and elderly people are most commonly affected because of the high prevalence of contact lens usage, systemic drug effects, autoimmune diseases, and refractive surgeries.

The epidemiology forecast for DES is supported by historical data obtained from peer-reviewed articles and population-based studies. The forecast methodology was kept consistent across the 8MM to allow for a meaningful comparison of the forecast prevalent cases of DES across these markets. These sources used questionnaires to assess DES symptoms, along with various diagnostic tests like aqueous tear flow, ocular surface damage, and measurements of tear film instability, for the 8MM in this analysis.

In the 8MM the total prevalent cases of DES are expected to increase from 267,680,785 cases in 2016 to 286,308,974 cases in 2026, at an Annual Growth Rate (AGR) of 0.70%. In 2026, China will have the highest number of total prevalent cases of DES in the 8MM with 205,637,090 total prevalent cases, whereas Spain will have the fewest number of total prevalent cases with 3,488,142 total prevalent cases in 2026. In the 8MM, the diagnosed prevalent cases are expected to increase from 100,585,137 cases in 2016 to 108,896,818 cases in 2026, at an AGR of 0.83%. In 2026, China will have the highest number of diagnosed prevalent cases of DES in the 8MM, with 64,251,395 diagnosed prevalent cases, whereas Spain will have the fewest number of diagnosed prevalent cases with 1,807,984 cases.

Scope

- The Dry Eye Syndrome (DES) Epidemiology Forecast Report provides an overview of the risk factors and global trends of DES in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China).
- This report also includes a 10-year epidemiology forecast for the diagnosed prevalent cases and total prevalent cases (both diagnosed and undiagnosed) of DES. The total prevalent cases and diagnosed prevalent cases of DES are segmented by sex, severity (mild, moderate, and severe), and age in 10-year increments (starting at ages 20-29 years and ending at ages 80 years and older).
- The Dry Eye Syndrome epidemiology forecast report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Dry Eye Syndrome (DES) Epidemiology Forecast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global DES market.
- Quantify patient populations in the global DES market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DES therapeutics in each of the markets covered.
- Understand magnitude of DES population by severity.
Publisher Name : GlobalData


1.1 List of Tables 3
1.2 List of Figures 3
2 Dry Eye Syndrome: Executive Summary 4
2.1 Related Reports 6
2.2 Upcoming Reports 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 7
3.3 Global and Historical Trends 8
3.4 Forecast Methodology 9
3.4.1 Sources 9
3.4.2 Forecast Assumptions and Methods - Population 12
3.4.3 Forecast Assumptions and Methods - Total and Diagnosed Prevalent Casesof DES 12
3.4.4 Forecast Assumptions and Methods - Total and Diagnosed Prevalent Cases of DES by Severity 15
3.5 Epidemiological Forecast for DES (2016-2026) 17
3.5.1 Total Prevalent Cases of DES 17
3.5.2 Age-Specific Total Prevalent Cases of DES 18
3.5.3 Sex-Specific Total Prevalent Cases of DES 19
3.5.4 Total Prevalent Cases of DES by Severity 20
3.5.5 Diagnosed Prevalent Cases of DES 21
3.5.6 Diagnosed Prevalent Cases of DES by Severity 22
3.6 Discussion 23
3.6.1 Epidemiological Forecast Insight 23
3.6.2 Limitations of Analysis 23
3.6.3 Strengths of Analysis 24
4 Appendix 25
4.1 Bibliography 25
4.2 About the Authors 27
4.2.1 Epidemiologist 27
4.2.2 Reviewers 27
4.2.3 Global Director of Therapy Analysis and Epidemiology 28
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 28
4.3 About GlobalData 29
4.4 Contact Us 29
4.5 Disclaimer 29

List Of Tables

1.1 List of Tables
Table 1: Risk Factors and Comorbid Conditions Associated with DES 8

List Of Figures

1.2 List of Figures
Figure 1: Total Prevalent Cases of DES, Both Sexes, Ages 20 Years, N, 2016 and 2026 5
Figure 2: Diagnosed Prevalent Cases of DES, Both Sexes, Ages 20 Years, N, 2016 and 2026 6
Figure 3: 8MM, Age-Standardized Total Prevalence of DES (%), Both Sexes, Ages 20 Years, 2016 9
Figure 4: 8MM, Sources Used and Not Used to Forecast the Total Prevalent Cases of DES 10
Figure 5: 8MM, Sources Used and Not Used to Forecast the Diagnosed Prevalent Cases of DES 11
Figure 6: 8MM, Sources Used to Forecast the Severity of DES 12
Figure 7: 8MM, Total Prevalent Cases of DES, Both Sexes, Ages 20 Years, N, 2016 17
Figure 8: 8MM, Age-Specific Total Prevalent Cases of DES, Both Sexes, Ages 20 Years, N, 2016 18
Figure 9: 8MM, Sex-Specific Total Prevalent Cases of DES, Both Sexes, Ages 20 Years, N, 2016 19
Figure 10: 8MM, Total Prevalent Cases by Severity, Both Sexes, Ages 20 Years, N, 2016 20
Figure 11: 8MM, Diagnosed Prevalent Cases of DES, Both Sexes, Ages 20 Years, N, 2016 21
Figure 12: 8MM, Diagnosed Prevalent Cases by Severity, Both Sexes, Ages 20 Years, N, 2016 22

Keratoconjunctivitis Sicca (Dry Eye) - Pipeline Review, H2 2018 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Keratoconjunctivitis Sicca (Dry Eye) - Pipeline Review, H2 2018, provides an overview

View Report

Dry Eye Syndrome: Global Drug Forecast and Market Analysis to 2026 Dry Eye Syndrome (DES) is a multifactorial disease of the tears and ocular surface that causes ocular discomfort, visual disturbances,

View Report

Parkinsons Disease: Global Drug Forecast and Market Analysis to 2026 Parkinsons disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports